Free Trial
→ Your free book expires (From Profits Run) (Ad)tc pixel Free MVI Stock Alerts

Marwyn Value Investors (MVI) Stock Chart & Stock Price History

Marwyn Value Investors logo
GBX 136 0.00 (0.00%)
As of 07:54 AM Eastern
Compare

Marwyn Value Investors Stock Price Performance

The Marwyn Value Investors (MVI) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 25.46%, with a year-to-date return of -2.16%. In the past month, the stock has increased 1.87%, reflecting recent market activity.

As of the latest close, Marwyn Value Investors traded at GBX 136 with a market cap of £76.89 million and volume of 90,000 shares. Five years ago, the stock traded at GBX 115, representing a 18.26% increase over that period. At the time, it had a market cap of £70.75 million and a volume of 7,300 shares.

Receive MVI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Marwyn Value Investors and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
5 Day
Performance
+0.04%
1 Month
Performance
+1.87%
3 Month
Performance
-2.24%
Year-To-Date
Performance
-2.16%
1 Year
Performance
+25.46%
5 Year
Performance
+18.26%

MVI Stock Chart for Thursday, May, 14, 2026

MVI Chart by TradingView

Marwyn Value Investors Stock Price History

Export
DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization
05/13/2026GBX 135GBX 136
+0.74%		GBX 136GBX 13690,000 shs£76.89 million
05/12/2026GBX 134.25GBX 135
+0.56%		GBX 137.80GBX 134.10390,390 shs£76.32 million
05/11/2026GBX 135.95GBX 134.25
-1.25%		GBX 136GBX 133.5081,230 shs£75.90 million
05/08/2026GBX 132GBX 135.95
+2.99%		GBX 135.95GBX 1327,304 shs£76.39 million
05/07/2026GBX 132GBX 132GBX 132GBX 131.252,636 shs£74.63 million
05/06/2026GBX 131GBX 132
+0.76%		GBX 135.90GBX 13289,796 shs£74.63 million
05/05/2026N/AGBX 131GBX 136GBX 13152,868 shs£74.06 million
04/30/2026GBX 131.77GBX 136
+3.21%		GBX 136GBX 133.5014,500 shs£76.89 million
04/29/2026GBX 131.60GBX 131.77
+0.13%		GBX 133.50GBX 131.77908 shs£74.50 million
04/28/2026GBX 131.60GBX 131.60GBX 133.50GBX 131.602,500 shs£74.40 million
04/27/2026GBX 133.50GBX 131.60
-1.42%		GBX 133.50GBX 131.602,500 shs£74.40 million
04/24/2026GBX 135.75GBX 135.75GBX 135.75GBX 131.5046,000 shs£76.75 million
04/23/2026GBX 131.50GBX 135.75
+3.23%		GBX 135.75GBX 131.5046,000 shs£76.75 million
04/22/2026GBX 135.75GBX 131.50
-3.13%		GBX 133.50GBX 131.503,500 shs£74.34 million
04/21/2026GBX 135.75GBX 135.75GBX 135.75GBX 133.50109,922 shs£76.75 million
04/20/2026GBX 131.25GBX 135.75
+3.43%		GBX 135.75GBX 133.50109,922 shs£76.39 million
04/17/2026GBX 131.05GBX 131.25
+0.15%		GBX 133.50GBX 131.255,000 shs£76.39 million
04/16/2026GBX 131GBX 131.05
+0.04%		GBX 133.50GBX 131.0513,186 shs£74.09 million
04/15/2026GBX 133.50GBX 131
-1.87%		GBX 134.40GBX 13145,829 shs£74.06 million
04/14/2026GBX 131GBX 133.50
+1.91%		GBX 134.50GBX 13121,326 shs£76.39 million
04/13/2026GBX 131GBX 131GBX 134.50GBX 13121,326 shs£74.06 million
Related Companies

This page (LON:MVI) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners
Microscopic Footage Shows Immune Cells Attacking Cancer
Early human trial data from one NASDAQ-listed biotech showed up to a 63.7% reduction in cancer burden using it...
Market Tactic | Sponsoredtc pixel
Before you buy SpaceX shares, consider this alternative approach
SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceedin...
Weiss Ratings | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
The US sanctioned itself out of world reserve status…
Russia and Iran are both bypassing the US petrodollar - settling oil trades in alternative currencies while ce...
Golden Portfolio | Sponsoredtc pixel
Peptide Company Lands Exclusive MMA Wellness Partnership
A publicly traded peptide company just signed an exclusive partnership with a NYSE-listed MMA media platform t...
The Tomorrow Investor | Sponsoredtc pixel
Collect $1,170 a month from silver
I've Rarely Seen This With Silver This combination - 20% dividends + 68% share appreciation - never happens...
Investors Alley | Sponsoredtc pixel
Your temporary download link is expiring
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel